~ Amit Chopra, Managing Director India & South Asia Thermo Fisher Scientific We are on the cusp of a new era of transformation in healthcare, which is now central to economic-growth worldwide. Post pandemic, the industry continues to witness leaps in technological advancements and innovations, leading
Partnership to focus on advanced molecular diagnostic solutions for key health challenges including diabetic foot infection – reducing risk of serious complications Mylab Discovery Solutions, India’s leading biotech company, and DnaNudge, a UK-based pioneer of consumer genetics testing and medical diagnostics, today announced a
Global Health Limited (NSE: Medanta, BSE: 543654), one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, today announced its unaudited consolidated financial results for the quarter and nine months ending 31st December, 2022. Highlights of the Nine
Price Band fixed at ₹ 319 to ₹ 336 per equity share of face value of ₹ 2 each of Global Health Limited (“Equity Shares”) Bid /Offer Opening Date – Thursday, November 03, 2022 and Bid/ Offer Closing Date – Monday, November 07, 2022 Global
The Global South Impact Community, convened by The Rockefeller Foundation and International Venture Philanthropy Center (IVPC) is comprised of senior leaders from public, private, and philanthropic institutions across the Global South By sharing its/the group’s official Statement, the group/Mr. Bambang Brodjonegoro called on G20
Global Health, best known as the owner of Medanta, a chain of hospitals in north and east India, has sought the markets regulator’s approval for its initial public offering (IPO). As part of the IPO, Global Health, founded by Naresh Trehan, a cardiovascular surgeon, and Sunil Sachdeva, an entrepreneur, will sell new
